Genes2Me NGS-based Clinical Panels
Cancer Genetics & Precision Medicine
Providing a whole range of focused NGS panels from Genes2Me (G2M) dedicated and capable of providing diagnosis and prognostic solutions for prevention as well as treatment of a variety of genetic and somatic cancers, Cardiovascular, Respiratory and Neurological disorders and capture of drug metabolism related genes.
Genes2Me NGS-based Clinical Panels are compatible with all NGS platforms from Illumina, Thermo Fisher ION and MGI. G2M's target enrichment method is capable of specifically isolating your genomic loci of interest out of the whole genome & increasing the sensitivity of detecting genetic mutations by producing higher coverage & in-depth sequencing data.
Advances in single cell RNA quantification techniques have enabled comprehensive study of cell subpopulations within a heterogeneous population. The GEM code technology from 10X Genomics, which combines microfluidics with molecular barcoding and custom bioinformatics software, enables analyzing the transcriptomes of thousands of cells at single cell resolution.
CliSeq Interpreter uses algorithms that are fine tuned to work with Genes2Me NGS Clinical panels designed for oncology, liquid biopsy, pharmacogenomics, common and rare genetic diseases in detecting low frequency variants with high sensitivity to achieve clinical applications Cliseq Interpreter interface is browser based and simple clicks to select and upload the data. This pipeline implements typical NGS workflow by allowing fewer clicks and user’s input data.